- Ripple Continues Massive RLUSD Minting Spree on XRPL
- Peter Schiff Says Bitcoin Is Not Real Asset
- Shiba Inu's 1020% Burn Rate Spike Incinerates 20.82 Million SHIB Tokens
- Nvidia invests $3.5 billion in MediaTek convertible bonds
- Global Water Resources declares monthly dividend of USD 0.03 a share
- Bitcoin ETF inflows end streak with $201.8 million outflow, regulatory test looms
- Shiba Inu (SHIB) Loses 42% of Exchange Outflows: Is Sellout Closer?
- Crypto Developer Dodges Hidden Malware After Clicking Fake Claude AI Link
- Bitcoin Logs Strongest August in Nine Years, Setting Stage for Q4
- Shiba Inu (SHIB) Might Lose Most Important Level of 2026
- Ripple CTO Emeritus Slams Bitcoin's BIP-110 Legacy Chain Fix: 'Listen to Yourself'
- Ripple Exec: Clarity Act Can Unlock More US Jobs
- 105% Imbalance: Higher XRP Prices Push AI Wallets Deeper Into RLUSD
- Nations Royalty swings to FY27 Q1 net income of C$840,000; revenue rises 1,058% year over year to C$2.21 million
- American Battery Technology hosts DOE, Nevada officials at Reno battery recycling facility tour
- Teladoc Health Names Michael Grasher CFO
- Oil: geopolitical support and Venezuela deal risk – BNY
- RingCentral, Digital Island Collaborate to Offer AI-Powered Communications Platform in New Zealand
- Zentek corrects OTC Markets trading start day to Wednesday, Sept. 2, 2026
- Alpha Tau Medical Completes Patient Enrollment in Pancreatic Cancer Study
- DBS backs SGD 5 billion sustainability-linked loan for KKR, Singtel STT GDC deal
- Montega reiterates buy on Nynomic, sets EUR 30 price target
- GE HealthCare's Photonova Spectra System Receives CE Mark
- Teladoc Health Names Michael Grasher Chief Financial Officer
- Max Stock cuts proposed CEO monthly fee cap to ILS 240,000 ahead of Sept. 15 EGM
- Max Stock shareholders vote Sept. 15 on amended CEO compensation policy, Ori Max pay terms
- UIPATH INC : UBS RAISES TARGET PRICE TO $19 FROM $12
- KAISER ALUMINUM CORPORATION <KALU.O>: UBS RAISES TARGET PRICE TO $184 FROM $179
- KAISER ALUMINUM CORPORATION <KALU.O>: UBS RAISES TARGET PRICE TO $184 FROM $179
- Optimum Expands Multi-Year Agreement With T-Mobile
- Ahlsell names CEO Claes Seldeby as acting head of Ahlsell Sverige after Helfridsson exit
- Federal Reserve: Warsh’s hawkish shift reshapes rate outlook – Rabobank
- Cruzeiro do Sul Educacional announces extraordinary shareholder meeting
- Medalist Diversified CFO C. Brent Winn Jr acquires $3,072 of common shares
- --Maxim Initiates Deep Fission at Buy With $17 Price Target
- Market Chatter: PG&E Shares Slide Premarket as California Lawmakers Block Wildfire Damage Cap
- Argus Adjusts Price Target on Salesforce to $300 From $290, Maintains Buy Rating
- Emergent BioSolutions Awarded Standing Offer for Narcan Nasal Spray in Canada
- Solana market liquidation wipes out $2.2M as SOL price stalls
- Seeker Price Prediction: SKR Open Interest Explodes as September Breakout Looms
- Solana Price Prediction: Can SOL Reach $500?
- Germany's inflation edges up, reinforcing the case for ECB rate hike
- XRP must rally 45% to reach $2 as ETF inflows surge to $1.66 billion
- Cognizant, CrowdStrike expand collaboration to launch OT cybersecurity service powered by Falcon for XIoT
- Innventure names Bruce Brown board chairman as Otworth steps down
- Arch Biopartners wins central IRB approval for Phase II LSALT peptide CS-AKI trial in US
- PNC president, CFO to speak at Barclays Global Financial Services Conference
- DEAG publishes presentation for Aug. 25, 2026 annual general meeting
- NurExone Biologic Posts Unchanged Q2 Loss Per Share
- Nvidia Looks Like a Growth Stock Again. Watch Cathie Wood. -- Barrons.com
- Robinhood Chain Revenue Tops Ethereum In 24-Hour App Metrics
- EU aviation safety agency narrows Gulf airspace warning
- Alligator Bioscience registers prospectus for unit rights issue with free warrants
- PROTAGONIST THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $170 FROM $167
- Amarin highlights REDUCE-IT post hoc study linking icosapent ethyl to lower tissue factor levels, fewer CV events
- sino posts FY26 nine-month pretax profit more than doubled to EUR 3.49 million; net profit rises 63.11% to EUR 623,000 in Q3
- AGCO opens expanded Visalia, California parts distribution center to boost West Coast capacity
- Hyperfine to attend Lake Street Capital Markets Best Ideas Growth Conference
- German inflation accelerates in August on higher energy prices
- GFL Environmental Price Target Raised to C$82 at CIBC
- HawkEye 360 Agrees to Release of Shares; to Be Added to Russell 2000
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. -- Barrons.com
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Why the Tech Stocks Rally is Under Threat From Surging Rate-Hike Odds -- Barrons.com
- PyroGenesis Secures Second Titanium Powder Contract with US Client
- Deere Gets an Upgrade as Baird Bets Big on a Farm Recovery -- Barrons.com
- BUZZ-Aon slips after reaching $17 bln deal for insurance brokerage USI
- BUZZ-AON slips after reaching $17 bln deal for insurance brokerage USI
- Palvella Therapeutics Completes Rolling Submission of NDA for QTORIN Rapamycin
- Corvex Expects Fivefold Increase in Data Center Power Capacity
- TransCode says preclinical study shows survival benefit for TTX-MC138 in breast cancer bone metastasis model
- Majestic Gold FY26 H1 net income rises 25.5% to $12.6 million; revenue increases 23.2% to $52.7 million
- Chemomab CEO Adi Mor presents at H.C. Wainwright Global Investor Conference
- Krait Critical Minerals updates due diligence, exclusivity on Bales Antimony deal talks
- Silvercorp Metals announces availability of fiscal 2026 sustainability report
- BioVie completes treatment phase of Phase 2 Long COVID trial for bezisterim
- Decade Resources drills into porphyry-style copper mineralization at Bonaparte project in British Columbia
- Cadrenal Therapeutics wins FDA alignment on Phase 3 CAD-1005 trial design in heparin-induced thrombocytopenia
- PennantPark Senior Secured Loan Fund I resets USD 316.7 million securitization, cuts borrowing spread to SOFR+1.82%
- National Bank of Canada wins final regulatory approval for Laurentian Bank retail, SME portfolio deal
- Teladoc Health appoints Michael Grasher as CFO
- AUO to showcase Micro LED co-packaged optics module at SEMICON Taiwan
- Constellation Software’s Volaris Group acquires France-based Biodiv-Wind
- OnKure Therapeutics to join Morgan Stanley Global Healthcare Conference, holds investor meetings
- BRIEF-Activist Pushes EPAM Systems For Buybacks As AI Hits Its Shares - FT
- Mobix Labs: Vision Aerial Projects 2027 Rev Would Approach Three Times Its 2025 Rev >MOBX
- D2HFP fund challenges Cruzeiro do Sul board nominee ahead of Sept. 1 EGM, citing alleged competitor role at Einstein
- RF Industries to report fiscal Q3 results, host conference call
- Elicio Therapeutics CEO, CSO to join H.C. Wainwright Global Investment Conference fireside chat
- Franklin Templeton funds pay August distributions, BWG at $0.08 per share
- BRIEF-Jennmar Announces Partnership With Outokumpu's Kemi Mine
- Pinnacle Financial Partners CEO, CFO to join fireside chat at Barclays Global Financial Services Conference
- Sterling Metals appoints former QcX CEO Albert Contardi to board
- GE HealthCare Photonova Spectra photon-counting CT system wins CE Mark approval
- Dick’s Sporting Goods to join Goldman Sachs Global Consumer and Retail Conference fireside chat
- C1 Fund Q2 NAV stands at USD 42.63 million, or USD 6.49 a share
- Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
